Company Monitoring Page for Alkermes

latest headlines for company on cafepharma

Alkermes Outlook Remains Bleak
Yahoo/Zacks.com
Tue, 05/26/09 - 11:05 am
Tags:
Alkermes
Alkermes: Risperdal Consta gets expanded approval
Yahoo/AP
Mon, 05/18/09 - 11:29 am
Tags:
Alkermes, Risperdal Consta, FDA, bipolar disorder
FDA Calendar Updates: Amylin, Alkermes, Eli Lilly, Cell Therapeutics
Seeking Alpha
Wed, 05/6/09 - 07:16 am
Tags:
Cell Therapeutics, Eli Lilly, FDA, Alkermes, Amylin
Amylin, Alkermes rally on FDA filing
Marketwatch
Tue, 05/5/09 - 10:32 am
Tags:
Amylin, Alkermes, FDA
FDA, Clinical Trial Calendar Updates: Acorda, Alkermes, GTx
Seeking Alpha
Thu, 04/23/09 - 10:04 am
Tags:
FDA, drug trials, Acorda Therapeutics, GTx, Alkermes
Reworking the Broken R&D Model
Motley Fool
Wed, 04/22/09 - 07:13 am
Tags:
R&D, GSK, Merck, Isis Pharmaceuticals, Alnylam, Bristol-Myers Squibb, Gilead Sciences, Pfizer, Alkermes, Amylin
Which Diabetes Drugs Will Win Out?
Seeking Alpha
Thu, 04/2/09 - 06:12 am
Tags:
diabetes, Alkermes, Eli Lilly, Amylin, AstraZeneca, Bristol-Myers Squibb, GSK, Takeda, Merck, Novo Nordisk
Amylin, Novo Nordisk buck downward trend
Marketwatch
Wed, 04/1/09 - 03:50 pm
Tags:
Amylin, Novo Nordisk, Celgene, Eli Lilly, Alkermes, AstraZeneca
Pharma's Big Drug Test
CNBC
Wed, 04/1/09 - 06:15 am
Tags:
Merck, GSK, Alkermes, Eli Lilly, Amylin, AstraZeneca, Bristol-Myers Squibb
Bristol-Myers, Novo Nordisk diabetes drugs face FDA review, while Amylin preps for application
Yahoo/AP
Thu, 03/26/09 - 02:46 pm
Tags:
Bristol-Myers Squibb, Novo Nordisk, FDA, Amylin, Alkermes, saxagliptin, Byetta
Alkermes advanced after analyst upgrades shares on expected Risperdal Consta strength
Yahoo/AP
Fri, 12/19/08 - 10:26 am
Tags:
Alkermes, Risperdal, JNJ, Eli Lilly

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.